Sales 2024 * | 29.4B 4.2B | Sales 2025 * | 31.35B 4.48B | Capitalization | 178B 25.39B |
---|---|---|---|---|---|
Net income 2024 * | 3.86B 551M | Net income 2025 * | 5.09B 727M | EV / Sales 2024 * | 6.53 x |
Net Debt 2024 * | 14.23B 2.03B | Net Debt 2025 * | 12.54B 1.79B | EV / Sales 2025 * | 6.07 x |
P/E ratio 2024 * |
43.4
x | P/E ratio 2025 * |
33.4
x | Employees | - |
Yield 2024 * |
1.51% | Yield 2025 * |
1.75% | Free-Float | 75.38% |
Latest transcript on Novozymes A/S
1st Jan change | Capi. | |
---|---|---|
-27.03% | 3.21B | |
+12.95% | 1.73B | |
-21.15% | 547M | |
-26.48% | 374M | |
-81.65% | 216M | |
-14.15% | 111M |